Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2012 2
2013 3
2014 3
2015 3
2016 5
2017 4
2018 4
2019 2
2020 4
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Dokkathin
Page 1
Vitamin D and Age-Related Macular Degeneration.
Layana AG, Minnella AM, Garhöfer G, Aslam T, Holz FG, Leys A, Silva R, Delcourt C, Souied E, Seddon JM. Layana AG, et al. Nutrients. 2017 Oct 13;9(10):1120. doi: 10.3390/nu9101120. Nutrients. 2017. PMID: 29027953 Free PMC article. Review.
Patient perceptions and experiences of stereotactic radiotherapy for wet age-related macular degeneration.
Senra H, Joseph S, Balaskas K, Horani M, Aslam T. Senra H, et al. Eur J Ophthalmol. 2016 Jun 10;26(4):e80-2. doi: 10.5301/ejo.5000739. Eur J Ophthalmol. 2016. PMID: 26833232
A novel approach to treatment with the use of stereotactic radiotherapy (Oraya IRay) as an adjunct to ranibizumab injections has shown promising results. We explored patients' experiences of receiving Oraya therapy for wet ARMD. METHODS: We present a consecutive cas …
A novel approach to treatment with the use of stereotactic radiotherapy (Oraya IRay) as an adjunct to ranibizumab injections has show …
[Economic Short-Term Cost Model for Stereotactic Radiotherapy of Neovascular AMD].
Neubauer AS, Reznicek L, Minartz C, Ziemssen F. Neubauer AS, et al. Klin Monbl Augenheilkd. 2016 Aug;233(8):951-7. doi: 10.1055/s-0042-100473. Epub 2016 Apr 30. Klin Monbl Augenheilkd. 2016. PMID: 27130973 Clinical Trial. German.
OBJECTIVES: Stereotactic radiation therapy (Oraya, OT) is available as a second line therapy for patients who, despite intensive anti-VEGF therapy for neovascular AMD, do not show an improvement in CNV. ...
OBJECTIVES: Stereotactic radiation therapy (Oraya, OT) is available as a second line therapy for patients who, despite intensive anti …
[Adjuvant stereotactic low energy radiation therapy of exudative age-dependent macular degeneration (Oraya system)].
Pollithy S, Celik N, Höh H, Dithmar S. Pollithy S, et al. Ophthalmologe. 2013 May;110(5):460-3. doi: 10.1007/s00347-012-2741-6. Ophthalmologe. 2013. PMID: 23559322 German.
Stereotactic low-voltage x-ray irradiation seems to be a promising approach. For this purpose the Oraya system is available and has shown positive results in initial studies. ...
Stereotactic low-voltage x-ray irradiation seems to be a promising approach. For this purpose the Oraya system is available and has s …
StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trial.
Neffendorf JE, Desai R, Wang Y, Kelly J, Murphy C, Reeves BC, Chakravarthy U, Wordsworth S, Lewis C, Peacock J, Uddin S, O'Sullivan JM, Jackson TL. Neffendorf JE, et al. Trials. 2016 Nov 24;17(1):560. doi: 10.1186/s13063-016-1676-7. Trials. 2016. PMID: 27881184 Free PMC article. Clinical Trial.
METHODS/DESIGN: STAR is a multicentre, double-masked, randomised, sham-controlled clinical trial. It evaluates a new device (manufactured by Oraya, Newark, CA, USA) designed to deliver stereotactic radiotherapy (SRT) to nAMD lesions. ...
METHODS/DESIGN: STAR is a multicentre, double-masked, randomised, sham-controlled clinical trial. It evaluates a new device (manufactured by …
Kilovoltage stereotactic radiosurgery for age-related macular degeneration: assessment of optic nerve dose and patient effective dose.
Hanlon J, Lee C, Chell E, Gertner M, Hansen S, Howell RW, Bolch WE. Hanlon J, et al. Med Phys. 2009 Aug;36(8):3671-81. doi: 10.1118/1.3168554. Med Phys. 2009. PMID: 19746800
Research for new treatments of the wet form of the disease using kilovoltage stereotactic radiosurgery is currently underway at Oraya Therapeutics, Inc. In the present study, the authors extend their previous computational stylized model of a single treated eye [Med. ...
Research for new treatments of the wet form of the disease using kilovoltage stereotactic radiosurgery is currently underway at Oraya …
SU-E-T-477: Influence of Eye Size on Radiation Absorbed Dose Delivered to Non- Targeted Tissues during Stereotactic Radiosurgery for Age-Related Macular Degeneration.
Cantley J, Chell E, Firpo M, Hanlon J, Lee C, Bolch W. Cantley J, et al. Med Phys. 2012 Jun;39(6Part17):3815. doi: 10.1118/1.4735566. Med Phys. 2012. PMID: 28517457 Free PMC article.
CONCLUSIONS: The small variation in dose to the lens, central retinal artery, and optic nerve suggests that eye size does not significantly affect radiation dose to non-targeted eye tissues. This work was sponsored by Oraya Therapeutics....
CONCLUSIONS: The small variation in dose to the lens, central retinal artery, and optic nerve suggests that eye size does not significantly …
33 results